State Ledger
Company profile

OS Therapies Inc CIK 1795091

Ticker
OSTX (NYSE)
Industry
Pharmaceutical Preparations
Headquarters
Rockville, MD 20850
Fiscal year end
2025 (FY)
Market Data
Close
$1.62
Change
+$0.00
Change %
0.00%
Volume
10,211

OSTX · trading date Oct 9, 2026 · previous close $1.62 · source: Alpaca (IEX feed, not consolidated full-market data).

Key Financials
Revenue
—
Net income
-$28.75M
Total assets
$6.84M
Total liabilities
$11.86M
Stockholders' equity
-$6.10M
Cash & equivalents
$269.8K
Operating income
-$28.71M
Operating cash flow
-$14.24M
Capital expenditures
$466.4K

Fiscal year 2025, via 10-K filed 2026-03-31. A dash means this figure wasn't reported in the source filing under a field State Ledger recognizes - not that the value is zero.

Financial Performance
Operating margin
—
Net margin
—
Free cash flow
-$14.70M
Free cash flow margin
—
Liabilities / assets
173.5%
Equity / assets
-89.1%
CapEx / revenue
—
Operating cash flow / net income
0.50×

Derived from the fiscal year 2025 figures above. These metrics are mathematical calculations and do not represent a rating or assessment of the company.

Financial History
Fiscal yearRevenueNet incomeAssetsLiabilitiesEquity
2025 — -$28.75M $6.84M $11.86M -$6.10M
2024 — -$8.88M $5.54M $4.73M -$3.27M
2023 — -$7.79M $798.1K $24.81M -$24.02M
Company Details
SIC code
2834
State of incorporation
DE
Active filer
Yes
Most recent SEC filing
Form 8-K
2026-09-10
Financials filed via
Form 10-K
filed 2026-03-31

"Most recent SEC filing" may differ from the filing used for the financial figures above.

Location
Rockville, MD 20850
15825 SHADY GROVE ROAD
Data & Methodology

SEC EDGAR submissions API (identity, collected Sep 19, 2026, 15:11 UTC) and SEC XBRL Company Facts API (financials, collected Sep 26, 2026, 15:33 UTC) · figures as originally filed, not restated · a dash always means a value wasn't reported, never a real zero.

← Back to Maryland — Public Companies